Skip to main content

Read the latest news about clinical trials on Alzheimer's prevention with the participation of the Barcelonaβeta Brain Research Center (BBRC).

17 May | 2022

The BBRC, participating center in a new clinical trial

The international study Skyline plans to enroll 1.200 participants worldwide to assess a new treatment against Alzheimer's disease.

14 Jun | 2021

The United States approves the commercialization of a drug that could slow down Alzheimer's disease

The last drug approved by the FDA was in 2003, and until now any treatment has proved to slow down the progression of the disease.

16 Sep | 2020

The FDA accepts license application for aducanumab, the first possible disease modifying drug for Alzheimer’s

Dr José Luis Molinuevo comments the possible approval of Biogen’s new treatment, in an interview for the podcast Saving Minds.

11 Dec | 2019

BBRC and IMIM kick off a clinical trial of dementia prevention on people with memory problems

The PENSA Study will combine a program of interventions in lifestyle habits and the ingestion of a preparation based on a component from the green tea

22 Mar | 2019

Dr. José Luis Molinuevo on the closure of Biogen's clinical trials

The scientific director of BBRC's Alzheimer’s Prevention Program suggests trying a new aproach in order to keep working with Aducanumab

30 Oct | 2018

BBRC researchers participate in the 11th Clinical Trials on Alzheimer’s disease

CTAD conference took place in Barcelona, from the 24th to the 27th of October.

19 Apr | 2018

Barcelonaβeta Brain Research Center brings to Spain clinical trials in healthy people to prevent Alzheimer’s disease

The studies will analyze the efficacy of various pharmacological treatments designed to act before the manifestation of the clinical symptoms of the disease.